Skip to content

Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05004818
Enrollment
54
Registered
2021-08-13
Start date
2016-08-01
Completion date
2019-07-01
Last updated
2021-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Habituation, Motion Sickness, Seasickness, Vestibular Time Constant

Keywords

Motion Sickness, Seasickness, Galvanic vestibular stimulation, Rotatory chair, Vestibular time constant

Brief summary

subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.

Interventions

PROCEDUREGVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol

GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol

PROCEDURESham procedure

Participants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.

Sponsors

Medical Corps, Israel Defense Force
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
19 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* maximum score of 7 on the Wiker seasickness questionnaire in moderate sea conditions, with wave height of 0 - 1.5 m * All had been sailing regularly for at least six months before enrolling in the study

Exclusion criteria

* history of hearing loss * otoscopic findings of ear pathology * an implanted electrode * a finding of vestibulopathy on otoneurologic examination * withdrawal by any subject of his informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Vestibular time constantUntil one month following the interventionVestibular time constant was measured using repeated rotatory chair stimulation in step protocol.
Seasickness severityUntil one month following the interventionSeasickness severity as determined by Wiker questionnaire at set time frames following the intervention
scopolamine drug prescriptionUntil three months following the interventionscopolamine drug prescriptions were calculated for each participant and compared between the two groups
Anti-motion sickness clinic visitsUntil three months following the interventionAnti-motion sickness clinic visits were calculated for each participant and compared between the two groups

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026